Skip to main content

Peer Review reports

From: An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab

Original Submission
27 Jan 2014 Submitted Original manuscript
29 Jan 2014 Author responded Author comments - Reposo Ramírez-Lorca
Resubmission - Version 2
29 Jan 2014 Submitted Manuscript version 2
28 May 2014 Author responded Author comments - Reposo Ramírez-Lorca
31 Mar 2014 Reviewed Reviewer Report - Tereza Gabelic
17 Apr 2014 Reviewed Reviewer Report - Roberto Cappellani
Resubmission - Version 3
28 May 2014 Submitted Manuscript version 3
20 Jun 2014 Author responded Author comments - Reposo Ramírez-Lorca
9 Jun 2014 Reviewed Reviewer Report - Tereza Gabelic
Resubmission - Version 4
20 Jun 2014 Submitted Manuscript version 4
24 Jun 2014 Author responded Author comments - Reposo Ramírez-Lorca
Resubmission - Version 5
24 Jun 2014 Submitted Manuscript version 5
Publishing
25 Jun 2014 Editorially accepted
1 Jul 2014 Article published 10.1186/1471-2377-14-139

You can find further information about peer review here.

Back to article page